Please try another search
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Craig C. Parker | 61 | 2018 | CEO, President & Director |
Shao-Lee Lin | 56 | 2021 | Independent Director |
Eric H. Bjerkholt | 63 | 2023 | Independent Director |
Mace L. Rothenberg | 66 | 2021 | Independent Director |
Scott L. Friedman | - | 2022 | Member of Scientific Advisors |
Sarah Gillmor Hymowitz | - | 2022 | Member of Scientific Advisors |
Willard H. Dere | 70 | - | Member of Scientific Advisors |
Wen-Chen Yeh | 60 | 2016 | Member of Scientific Advisory Board |
Bart Williams | - | - | Member of Scientific Advisors |
David J. Woodhouse | 53 | 2020 | Independent Chairman of the Board |
Harold Eliot Varmus | - | - | Member of Scientific Advisors |
Mary Haak-Frendscho | 67 | 2021 | Independent Director |
Timothy W. Kutzkey | 48 | 2016 | Independent Director |
Anna Berkenblit | 54 | 2018 | Independent Director |
Christopher Y. Chai | 57 | 2021 | Independent Director |
Calvin Kuo | - | - | Co-Founder & Member of Scientific Advisor |
K. Christopher Garcia | - | - | Co-Founder & Member of Scientific Advisory Board |
Roeland Nusse | 74 | - | Co-Founder & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review